LECT2 and hepatocellular carcinoma: In addition, the changes in hepatic LECT2 expression are related to acute hepatitis (10), hepatic amyloidosis (11), nonalcoholic fatty liver disease (12), nonalcoholic steatohepatitis (13), liver fibrosis (14), and HCC (15).